Legal & General Group’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,122
Closed -$103K 3298
2017
Q3
$103K Buy
6,122
+845
+16% +$13.7K ﹤0.01% 2632
2017
Q2
$96K Hold
5,277
﹤0.01% 2629
2017
Q1
$105K Sell
5,277
-95
-2% -$2.21K ﹤0.01% 2512
2016
Q4
$136K Buy
5,372
+2,037
+61% +$48.1K ﹤0.01% 2381
2016
Q3
$78K Sell
3,335
-456
-12% -$10.7K ﹤0.01% 2317
2016
Q2
$74K Hold
3,791
﹤0.01% 2268
2016
Q1
$64K Hold
3,791
﹤0.01% 2310
2015
Q4
$85K Hold
3,791
﹤0.01% 2173
2015
Q3
$65K Hold
3,791
﹤0.01% 2307
2015
Q2
$52K Hold
3,791
﹤0.01% 2526
2015
Q1
$52K Hold
3,791
﹤0.01% 2472
2014
Q4
$40K Hold
3,791
﹤0.01% 2536
2014
Q3
$47K Buy
+3,791
New +$52.9K ﹤0.01% 2420

Legal & General Group's OME Position: Q4 2017 in Review

Legal & General Group sold out of Omega Protein (OME) in Q4 2017, closing a stake of 6,122 shares — an estimated $103K sold.

Legal & General Group first reported a position in OME in Q3 2014 and held it in 13 quarters. The position peaked at $136K in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Legal & General Group reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Legal & General Group sold 6,122 Omega Protein shares in Q4 2017, an estimated $103K.
  • Legal & General Group first reported a position in Omega Protein in Q3 2014 and held it in 13 quarters.
  • Legal & General Group's Omega Protein position peaked at $136K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Legal & General Group's 13F filing for Q4 2017, filed 13 Feb 2018.